WASHINGTON, Oct. 22 (Xinhua) -- American pharmaceutical company Moderna, the first to start clinical trials of a COVID-19 vaccine in the United States, finished enrolling all 30,000 of its participants for final stage trial on Thursday.
The Cambridge-based company said it has officially enrolled all 30,000 participants in the third phase of the trial, which involves two shots of the vaccination.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
